C4 Therapeutics (CCCC) Other Working Capital Changes (2019 - 2026)

C4 Therapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 6007.69% year-over-year to -$1.5 million in Q1 2026; TTM through Mar 2026 was -$7.3 million, a 669.57% decrease from a year earlier, with the FY2025 full-year figure at -$5.8 million, down 96333.33% from the prior year.
• Other Working Capital Changes grew to -$1.5 million in Q1 2026 per CCCC's latest filing, from -$5.9 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $20.9 million in Q4 2022 and bottomed at -$15.7 million in Q2 2022.
• The 5-year median for Other Working Capital Changes is -$2.3 million (2024), against an average of -$2882.4.
• Across the five-year window, Other Working Capital Changes soared 4925.0% in 2024 and sank 12351.06% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$575000.0 in 2022, then jumped by 92.52% to -$43000.0 in 2023, then decreased by 9.3% to -$47000.0 in 2024, then sank by 12351.06% to -$5.9 million in 2025, then jumped by 73.75% to -$1.5 million in 2026.
• Per Business Quant, the three latest CCCC Other Working Capital Changes figures stand at -$1.5 million (Q1 2026), -$5.9 million (Q4 2025), and $2.9 million (Q3 2025).